Dr. Reddy's Laboratories Limited Operating Expenses | RDY

Annual Operating Expenses Dr. Reddy's Laboratories Limited

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
119 B	95.9 B	82.2 B	84.4 B	78.8 B	61.2 B	63.8 B	64.3 B	64.8 B	62.6 B	59 B	49.8 B	38.9 B	34 B	27.6 B

All numbers in INR currency

Indicator range from annual reports

Maximum	Minimum	Average
119 B	27.6 B	65.7 B

Quarterly Operating Expenses Dr. Reddy's Laboratories Limited

2025-Q4	2025-Q1	2024-Q4	2024-Q1	2023-Q4	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	119 B	-	95.9 B	-	82.2 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in INR currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
119 B	82.2 B	98.9 B

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Zoetis ZTS	2.25 B	$ 71.41	2.45 %	$ 31.7 B	USA
Alterity Therapeutics Limited ATHE	16.7 M	$ 3.22	1.09 %	$ 20.6 B	Australia
Mirati Therapeutics MRTX	772 M	-	-	$ 3.3 B	USA
Gritstone Oncology GRTS	156 M	-	0.42 %	$ 213 M	USA
NexImmune NEXI	33 M	-	70.13 %	$ 4.12 M	USA
Harpoon Therapeutics HARP	100 M	-	-	$ 763 M	USA
InVivo Therapeutics Holdings Corp. NVIV	10.6 M	-	-37.48 %	$ 476 K	USA
Nymox Pharmaceutical Corporation NYMX	11.7 M	-	-19.68 %	$ 18.4 M	Canada
ObsEva SA OBSV	74.6 M	-	-15.52 %	$ 10.5 M	Schweiz
HOOKIPA Pharma HOOK	56.3 M	-	-6.92 %	$ 79.4 M	USA
Guardion Health Sciences GHSI	9.73 M	-	-0.31 %	$ 3.64 M	USA
Opiant Pharmaceuticals OPNT	42.6 M	-	-	$ 109 M	USA
Orchard Therapeutics plc ORTX	159 M	-	1.02 %	$ 90.8 M	Britain
La Jolla Pharmaceutical Company LJPC	61.4 M	-	-	$ 154 M	USA
Oyster Point Pharma OYST	120 M	-	-	$ 300 M	USA
Intercept Pharmaceuticals ICPT	560 M	-	-	$ 643 M	USA
9 Meters Biopharma NMTR	42 M	-	-42.97 %	$ 1.05 M	USA
Otonomy OTIC	42.6 M	-	-1.96 %	$ 4.68 M	USA
Chinook Therapeutics KDNY	57.1 M	-	-	$ 2.6 B	USA
Kaleido Biosciences KLDO	88.8 M	-	-3.69 %	$ 12.4 M	USA
Kronos Bio KRON	103 M	-	1.49 %	$ 50.8 M	USA
Landos Biopharma LABP	22.7 M	-	0.58 %	$ 144 M	USA
PhaseBio Pharmaceuticals PHAS	118 M	-	7.4 %	$ 6.29 M	USA
Provention Bio PRVB	141 M	-	-	$ 2.37 B	USA
Poseida Therapeutics PSTX	194 M	-	-	$ 857 M	USA
PolarityTE PTE	47.8 M	-	-0.82 %	$ 1.78 M	USA
Atreca BCEL	98.7 M	-	-11.76 %	$ 5.79 M	USA
Reata Pharmaceuticals RETA	280 M	-	-	$ 6.29 B	USA
Lumos Pharma LUMO	38.7 M	-	-	$ 35.3 M	USA
Stealth BioTherapeutics Corp MITO	46.3 M	-	-	$ 23.9 M	USA
Satsuma Pharmaceuticals STSA	70.9 M	-	-0.9 %	$ 36.5 M	USA
89bio ETNB	385 M	-	-	$ 1.55 B	USA
Syros Pharmaceuticals SYRS	139 M	-	-8.44 %	$ 3.4 M	USA
SpringWorks Therapeutics SWTX	81.3 M	-	-	$ 3.48 B	USA
Trevena TRVN	32.4 M	-	-46.58 %	$ 31.8 M	USA
Oncorus ONCR	76.5 M	-	-8.54 %	$ 3.19 M	USA
OncoSec Medical Incorporated ONCS	43.4 M	-	31.87 %	$ 1.61 M	USA
Y-mAbs Therapeutics YMAB	138 M	-	-	$ 382 M	USA
Oncternal Therapeutics ONCT	42.5 M	-	-24.12 %	$ 1.56 M	USA
Navidea Biopharmaceuticals NAVB	13.9 M	-	-2.99 %	$ 2.47 M	USA
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
BELLUS Health BLU	77.9 M	-	-	$ 2.47 B	Canada
bluebird bio BLUE	854 M	-	-	$ 546 M	USA
Intra-Cellular Therapies ITCI	228 M	-	-	$ 13.6 B	USA
CASI Pharmaceuticals CASI	38.9 M	-	-	$ 35.4 M	USA
ContraFect Corporation CFRX	64.6 M	-	-5.16 %	$ 5.39 M	USA
Turning Point Therapeutics TPTX	269 M	-	-0.13 %	$ 3.73 B	USA
Epizyme EPZM	236 M	-	-	$ 249 M	USA
Forward Pharma A/S FWP	3.39 M	-	-0.75 %	$ 18.7 M	Danmark